Moleculin Biotech (MBRX) Earnings (2015 - 2026)
Moleculin Biotech (MBRX) earnings from Sep 30, 2015 to Mar 31, 2026. The TTM Moleculin Biotech (MBRX) earnings is -$41M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Moleculin Biotech (MBRX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +58.76% |
| 3 Years TTM | +10.44% |
| 5 Years TTM | +14.50% |
| 10 Years TTM | +53.71% |
| All Time TTM | +34.08% |
Annual Earnings change of Moleculin Biotech (MBRX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$13M | -61.74% |
| 2025 | -$34M | +28.83% |
| 2024 | -$26M | -12.50% |
| 2023 | -$30M | +2.58% |
| 2022 | -$29M | +82.63% |
| 2021 | -$16M | -8.41% |
| 2020 | -$17M | +31.44% |
| 2019 | -$13M | +11.11% |
| 2018 | -$12M | +21.22% |
| 2017 | -$9.80M | +149.36% |
| 2016 | -$3.93M | +1686.36% |
| 2015 | -$220K | N/A |
Comparison Moleculin Biotech (MBRX) five years earnings CAGR with competitors
Moleculin Biotech (MBRX) five years earnings CAGR is 14.49%.